Icariin is a natural compound found in several plants, most notably the herb Epimedium. It has been used traditionally in Chinese medicine for various health benefits including potential blood pressure lowering effects. But what does the science say about icariin’s impact on hypertension? In this post, we’ll explore icariin’s mechanisms of action, research studies, safety, and effectiveness in reducing blood pressure.
Mechanisms of Action
Icariin might assist with bringing down pulse through a few instruments that advance vasodilation and increment nitric oxide creation.
Vasodilation
Hypertension is portrayed by expanded opposition in veins, decreasing the bloodstream. Vasodilation allows blood to flow more freely and lowers pressure by relaxing the walls of blood vessels.
Icariin has been displayed to expand the creation of nitric oxide (NO) and cGMP which are flagging particles that intervene in vasodilation. By loosening up vascular smooth muscle cells, icariin can broaden veins to further develop dissemination and lower circulatory strain.
Nitric Oxide Creation
Nitric oxide not only promotes vasodilation but also exhibits anti-inflammatory effects in blood vessels. This helps improve endothelial function. Impaired NO signaling is implicated in many cardiovascular diseases.
Studies indicate icariin enhances nitric oxide synthase activity and expression in endothelial cells of blood vessels. Icariin’s antioxidant properties help maintain NO levels by preventing oxidative degradation. This boost in NO contributes to icariin’s vasodilatory and hypotensive effects.
What is Icariin Used For?
In addition to potential blood pressure-lowering benefits, icariin is also used for:
- Improving erectile dysfunction
- Alleviating cardiovascular disease
- Enhancing cognitive function
- Reducing inflammation and oxidative stress
- Increasing testosterone levels
- Preventing bone loss
- Stimulating red blood cell production
- Protecting the liver and kidneys
However, more research is still needed to confirm many of these uses in humans. The most well-studied effects of icariin currently remain in the areas of sexual health and cardiovascular health.
Research Studies and Evidence
Animal Studies
A number of preclinical studies in rats and mice demonstrate icariin’s antihypertensive effects. One study in spontaneously hypertensive rats found epimedium extract lowered blood pressure by 13% and improved endothelial function over 8 weeks. Researchers also observed increases in NO production and vasodilation.
Other rodent studies show icariin prevents hypertension induced by glucocorticoids and regulates expression of eNOS – an enzyme central to NO activity and vasorelaxation. While promising, animal research has limitations in predicting human responses.
Human Studies
There are currently few clinical trials investigating icariin’s impact on blood pressure in humans. One little concentrate in postmenopausal ladies found icariin supplementation for quite a long time somewhat decreased systolic circulatory strain by 11 mmHg. However, there were no significant changes in arterial stiffness or diastolic pressure.
Another trial in prehypertensive men and women did not find major improvements in 24-hour ambulatory blood pressure with icariin compared to placebo after 8 weeks. The limited human data makes it difficult to draw firm conclusions on icariin’s antihypertensive efficacy. More randomized controlled trials are needed.
Does Icariin Powder Really Work?
Despite promising animal research, human studies are inconsistent regarding icariin’s effectiveness for lowering high blood pressure. The compound likely exhibits mild vasodilatory effects but these may not translate into dramatic reductions in hypertension for all individuals.
Factors like dosage, supplement purity/standardization, patient age and health status, and use of antihypertensive medications can all influence icariin’s blood pressure-lowering potential. Many claims regarding its efficacy currently lack rigorous evidence.
While icariin shows potential for supporting vascular health, those with hypertension should not rely solely on icariin supplements without also implementing lifestyle changes and consulting their doctor about proven medications. Icariin may provide a complementary benefit but more research is still needed.
Safety Profile of Icariin
Side Effects and Adverse Reactions
Icariin is generally well tolerated with a low risk of side effects at typical dosages up to 100-200 mg daily. Mild side effects occasionally reported include nausea, stomach upset, dizziness, and headaches.
Studies using high doses of icariin over 1000 mg/day for long periods have observed some liver and kidney toxicity in animals. But human studies using standard doses have not reported any liver, kidney, or other organ damage attributed to icariin supplementation.
Interactions with Medications and Health Conditions
Due to its ability to widen blood vessels and influence NO activity, icariin may potentially interact with antihypertensive medications, vasodilators, anticoagulants, and phosphodiesterase (PDE5) inhibitors like Viagra.
Those with bleeding disorders, liver/kidney impairment, or cardiovascular disease should use icariin cautiously or avoid use altogether until more safety data is available. Pregnant or nursing women should also avoid icariin supplements due to the lack of research on its effects in these populations.
Considerations and Limitations
Dosage and Standardization
Optimal dosing for icariin is not well established. Most studies use dosages between 100-200 mg daily. Due to variations in icariin content between supplement brands, it is important to choose a standardized extract with a verified icariin percentage.
Individual Variations
Icariin’s ability to lower blood pressure can vary widely between individuals based on factors like genetics, pre-existing health conditions, and medications used. Mild reductions seen in some may not occur in others. Talk to your doctor before using icariin specifically for blood pressure control.
While icariin shows theoretical promise as a natural compound to improve vascular function and possibly reduce hypertension, current evidence in humans remains limited. Work with your physician to determine if epimedium extract could be a helpful addition to your wellness regimen or blood pressure management protocol.
Endothelial Nitric Oxide Synthase (eNOS)
In vascular endothelial cells, it has been demonstrated that icariin raises eNOS expression in both mRNA and protein. eNOS is the chemical liable for catalyzing nitric oxide creation in the endothelium. By upregulating eNOS, icariin can enhance NO synthesis to support vasodilation.
Superoxide Dismutase (SOD)
Icariin also increases the activity of the antioxidant enzyme SOD which scavenges free radicals that can inactivate NO. By reducing oxidative stress, SOD helps maintain NO bioavailability for extended vasodilatory effects.
Cyclic guanosine monophosphate (cGMP)
Icariin blocks the enzyme that breaks down cGMP, phosphodiesterase type 5 (PDE5). This causes cGMP levels to increment, enacting flagging fountains that outcome in vasorelaxation and lower circulatory strain.
Effects on Anti-Inflammation
Inflammation causes damage to blood vessels and raises blood pressure. In the vascular endothelium, icariin reduces the production of inflammatory cytokines and the expression of adhesion molecules that are involved in inflammatory responses.
Angiotensin Converting Enzyme (ACE) Inhibition
Some research indicates icariin may block ACE activity, preventing the formation of the vasoconstrictor angiotensin II. This helps reduce blood pressure by preventing the narrowing of blood vessels.
In summary, icariin targets multiple mechanisms involved in blood vessel relaxation and regulation of vascular tone. It both increases vasodilatory signaling and reduces pathways that contribute to hypertension. More clinical studies are still needed to validate these effects in humans.
As a professional China epimedium Extract 10% Icariin supplier, botanical cube inc. is dedicated to providing high-quality Icariin horny goat weed extract. For more information or to place an order, please contact us at sales@botanicalcube.com.
References:
1. Ning, H., Xin, Z., Lin, Z., Song, W., & Guo, Y. (2006). Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology, 68(6), 1350-1354.
2. Zhu, W., Zhang, H., Yang, H., Jiang, X., & Li, X. (2020). Icariin: A promising ostheoporosis drug. Pharmacological Research, 151, 104569.
3. Zhang, Z., & Yang, Y. (2006). Icariin inhibits alloxan-induced apoptosis in pancreatic β-cells via attenuation of reactive oxygen species formation and endoplasmic reticulum stress. Apoptosis, 11(12), 2325-2332.
4. Ning, H., Xin, Z., Lin, Z., Banie, L., Lue, T. F., & Guo, Y. (2006). Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. The journal of sexual medicine, 3(4), 717-724.
5. Li, Y., Huang, X., Zhang, Y., Wang, Y., Li, K., Wei, Y., ... & Xu, D. (2014). Icariin Inhibits foam cell formation by suppressing NFκB activation and CD36 expression in oxidized low density lipoprotein-stimulated RAW 264.7 macrophages. Cell biochemistry and biophysics, 70(1), 689-696.